ArticleBreast cancer research : BCR2020

Mutant p53 drives the loss of heterozygosity by the upregulation of Nek2 in breast cancer cells.

Amr Ghaleb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.